Sorafenib 200 DRL


Film-coated tablet
scheduling status
S4
registration number
56/26/1136
What Sorafenib 200 DRL contains
Sorafenib.
other ingredients
Tablet core: Croscarmellose sodium Hypromellose Magnesium stearate Cellulose, microcrystalline Silica, colloidal anhydrous Sodium laurilsulfate Talc Tablet coating: Hypromellose Macrogol 3350 Titanium dioxide Iron oxide red.
Therapeutic classification
A26 Cytostatic agents.
© 2026 SAHPRA. ALL RIGHTS RESERVED